These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 27137657)

  • 1. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endoglin overexpression during embryoid body development.
    Baik J; Borges L; Magli A; Thatava T; Perlingeiro RC
    Exp Hematol; 2012 Oct; 40(10):837-46. PubMed ID: 22728030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
    Pearson S; Sroczynska P; Lacaud G; Kouskoff V
    Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
    Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
    Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
    Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
    Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
    Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
    Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesodermal patterning activity of SCL.
    Ismailoglu I; Yeamans G; Daley GQ; Perlingeiro RC; Kyba M
    Exp Hematol; 2008 Dec; 36(12):1593-603. PubMed ID: 18809240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.
    Park C; Afrikanova I; Chung YS; Zhang WJ; Arentson E; Fong Gh Gh; Rosendahl A; Choi K
    Development; 2004 Jun; 131(11):2749-62. PubMed ID: 15148304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCL/TAL1: a multifaceted regulator from blood development to disease.
    Porcher C; Chagraoui H; Kristiansen MS
    Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis.
    Martin R; Lahlil R; Damert A; Miquerol L; Nagy A; Keller G; Hoang T
    Development; 2004 Feb; 131(3):693-702. PubMed ID: 14729577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
    Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
    PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building multifunctionality into a complex containing master regulators of hematopoiesis.
    Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of retinoic acid and scl controls primitive blood development.
    de Jong JL; Davidson AJ; Wang Y; Palis J; Opara P; Pugach E; Daley GQ; Zon LI
    Blood; 2010 Jul; 116(2):201-9. PubMed ID: 20410509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCL-GFP transgenic zebrafish: in vivo imaging of blood and endothelial development and identification of the initial site of definitive hematopoiesis.
    Zhang XY; Rodaway AR
    Dev Biol; 2007 Jul; 307(2):179-94. PubMed ID: 17559829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.